Skip to content

MDMA research published in 2014

Page 4 of 4: studies 61 to 76 of 76, newest first. Back to the MDMA overview

Studies

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity

Biological Psychiatry January 10, 2014 Robin Carhart-Harris, Kevin Murphy, Robert Leech et al. 182 citations

The MTLs appear to be specifically implicated in the mechanism of action of MDMA, but further work is required to elucidate how the drug's characteristic subjective effects arise from its modulation of spontaneous brain activity.

DOI: 10.1016/j.biopsych.2013.12.015 (opens in new tab) MDMA Euphoriant Cerebral blood flow Amygdala +5

The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat.

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 3, 2014 Patrick Dawson, Jolanta Opacka-Juffry, James D Moffatt et al.

5-APB, commonly marketed as 'benzofury' is a new psychoactive substance and erstwhile 'legal high' which has been implicated in 10 recent drug-related deaths in the UK. This drug was available on the internet and in 'head shops' and was one of the most commonly sold legal highs up until its recent UK temporary ban (UK Home Office). Despite its prominence, very little is known about its...

Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat.

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 3, 2014 Brittney M Cox, Mrudang M Shah, Teri Cichon et al.

Adolescents and young adults disproportionately abuse 3,4-methylenedioxymethamphetamine (MDMA; 'Ecstasy'); however, since most MDMA research has concentrated on adults, the effects of MDMA on the developing brain remain obscure. Therefore, we evaluated place conditioning to MDMA (or saline) during late adolescence and assessed anxiety-like behavior and monoamine levels during abstinence. Rats...

The effect of MDMA-induced anxiety on neuronal apoptosis in adult male rats' hippocampus.

Folia biologica 2014 S Karimi, M Jahanshahi, M J Golalipour

Ecstasy or MDMA as a psychoactive drug and hallucinogen is considered one of the most commonly used drugs in the world. This psychotropic substance is discussed both as sexually stimulating and reducing fear and anxiety. Amphetamines also destroy neurons in some brain areas. The aim of this study was to investigate the effects of MDMA on anxiety and apoptosis of hippocampal neurons. Forty-two...

Prenatal Exposure to Alcohol and 3,4-Methylenedioxymethamphetamine (Ecstasy) Alters Adult Hippocampal Neurogenesis and Causes Enduring Memory Deficits

Developmental Neuroscience 2014 Juan J. Canales, Agueda Ferrer-Donato

Recreational drug use among pregnant women is a source of concern due to potential harmful effects of drug exposure on prenatal and infant development. The simultaneous abuse of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] and alcohol is prevalent among young adults, including young expectant mothers. Here, we used a rat model to study the potential risks associated with exposure to...

Full recovery after severe serotonin syndrome, severe rhabdomyolysis, multi-organ failure and disseminated intravascular coagulopathy from MDMA.

Heart & Lung 2014 O Davies, B Batajoo-Shrestha, J Sosa-Popoteur et al.

3, 4-methylenedioxymethamphetamine (MDMA), popularly known as "ecstasy" is a synthetic, psychoactive drug used recreationally for its euphoric and "energy increasing" effects. MDMA has been linked to several severe adverse effects including the development of serotonin syndrome and sudden death. Individuals of Asian descent have been shown to have a predisposition for these severe adverse...

Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.

Journal of Psychopharmacology January 2014 John Turner, Andrew C. Parrott, Julia Goodwin et al.

The recreational drug MDMA (3,4-methylenedioxymethamphetamine) or 'Ecstasy' is associated with heightened psychiatric distress and feelings of depression. The Drugs and Infancy Study (DAISY) monitored the psychiatric symptom profiles of mothers who used Ecstasy/MDMA while pregnant, and followed them over the first year post-partum. We compared 28 young women whom took MDMA during their...

The prevalence, intensity, and assessment of craving for MDMA/ecstasy in recreational users.

Journal of Psychoactive Drugs 2014 Alan K. Davis, Harold Rosenberg

This study evaluated the prevalence, intensity, and correlates of craving for MDMA/ecstasy among recreational users employing a new multi-item, self-report questionnaire reflecting experiences of desire, intention to use, and anticipated loss of control. Using a web-based data collection procedure, we recruited MDMA/ecstasy users (n = 240) to rate their agreement with eight craving statements...

Acute Effects of 3,4-Methylenedioxymethamphetamine and Methylphenidate on Circulating Steroid Levels in Healthy Subjects

Neuroendocrinology 2014 Julia Seibert, Cédric M. Hysek, Carlos A. Penno et al. 52 citations

3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') and methylphenidate are widely used psychoactive substances. MDMA primarily enhances serotonergic neurotransmission, and methylphenidate increases dopamine but has no serotonergic effects. Both drugs also increase norepinephrine, resulting in sympathomimetic properties. Here we studied the effects of MDMA and methylphenidate on 24-hour plasma...

DOI: 10.1159/000364879 (opens in new tab) Methylphenidate Steroid Endocrinology Pharmacology +1

Religious Ecstasy and Other Intense Emotions

Religion and Spirituality Across Cultures 2014 Ralph W. Hood 1 citation

Positive psychology and the psychology of religion share an interest in understanding positive emotions and their contribution to human flourishing. The focus of this chapter is upon ecstatic and mystical states framed within Fisher’s model of ergotropic and trophotropic arousal allowing for a neurophysiological correlate of two states of consciousness widely recognized in the psychology of...

Maternal MDMA administration in mice leads to neonatal growth delay

The Journal of Toxicological Sciences 2014 Asuka Kaizaki, Sachiko Tanaka, Takemi Yoshida et al. 18 citations

The psychoactive recreational drug 3,4-methylenedioxymethamphetamine (MDMA) is widely abused. The fact that MDMA induces neurotoxic damage in serotonergic nerve endings is well known. However, the effects of MDMA on pregnant and neonatal animals remain unknown. Therefore, we studied the effects of gestational exposure to MDMA on birth, growth, and behavior of pups. Female BALB/c mice were...

Effects of Stress and MDMA on Hippocampal Gene Expression

BioMed Research International 2014 Georg F. Weber, Bethann N. Johnson, Bryan K. Yamamoto et al. 19 citations

MDMA (3,4-methylenedioxymethamphetamine) is a substituted amphetamine and popular drug of abuse. Its mood-enhancing short-term effects may prompt its consumption under stress. Clinical studies indicate that MDMA treatment may mitigate the symptoms of stress disorders such as posttraumatic stress syndrome (PTSD). On the other hand, repeated administration of MDMA results in persistent deficits...

MDMA and the “Ecstasy Paradigm”

Journal of Psychoactive Drugs 2014 Jon C. Cole 34 citations

For nearly 30 years, there has been a steady flow of research papers highlighting the dangers of MDMA and the implications for ecstasy users. After such a long time, it would be reasonable to expect that these dangers would be obvious due to the large number of ecstasy users. The available evidence does not indicate that there are millions of ecstasy users experiencing any problems linked to...

The Potential Dangers of Using MDMA for Psychotherapy

Journal of Psychoactive Drugs 2014 A. C. Parrott 60 citations

MDMA has properties that may make it attractive for psychotherapy, although many of its effects are potentially problematic. These contrasting effects will be critically reviewed in order to assess whether MDMA could be safe for clinical usage. Early studies from the 1980s noted that MDMA was an entactogen, engendering feelings of love and warmth. However, negative experiences can also occur...

Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs

Natural Product Reports 2014 Giovanni Appendino, Alberto Minassi, Orazio Taglialatela‐scafati 65 citations

Covering: up to December 2013. Over the past decade, there has been a growing transition in recreational drugs from natural materials (marijuana, hashish, opium), natural products (morphine, cocaine), or their simple derivatives (heroin), to synthetic agents more potent than their natural prototypes, which are sometimes less harmful in the short term, or that combine properties from different...

DOI: 10.1039/c4np00010b (opens in new tab) Mescaline MDMA Recreational drug Internet privacy +8

The rise of new psychoactive substance use in Australia.

Drug Testing and Analysis 2014 Lucy Burns, Amanda Roxburgh, Allison J Matthews et al. 78 citations

New Psychoactive Substances are now a feature of Australia's recreational drug market. Little is known, however, about the prevalence of use, the characteristics of people who use them and the relationship between the NPS and ecstasy markets. This study examined the prevalence and correlates of NPS use amongst a group of regular ecstasy users in Australia. Participants were recruited if they...

DOI: 10.1002/dta.1626 (opens in new tab) Full text (opens in new tab) Ecstasy New psychoactive substances Prevalence Nps +1